Clinical Pharmacology

Clinical Pharmacology Seminar CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 7 (CP7) Topics Include:  Manage Diabetic Macular Edema, Treatments for a Patient with Metastatic Melanoma, PTH, Hormone Replacement Therapy During and After Menopause, Side Effects of Drugs Approved for Treatment of Obesity, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
CP7
Full Course Price:
$580
Short Course:
CP7A, CP7B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Diabetic Macular Edema

Implement appropriate treatment strategies to manage diabetic macular edema; Counsel a diabetic patient about the importance of timely, regular treatment of diabetic eye disease; Recognize the roles of anti-vascular endothelial growth factor (EGF) agents and corticosteroids in the management of diabetic macular edema; Anticipate systemic risks associated with intraocular anti-EGF treatment; Explain the effect of EGF on perfusion in the diabetic retina.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Menopause

List absolute and relative contraindications to hormone replacement therapy during and after menopause; Explain why transdermal estrogen is preferred over other routes for treatment of vasomotor symptoms of menopause; Manage a patient with vasomotor symptoms who is taking tamoxifen; Counsel a patient regarding effective and ineffective nonpharmacologic treatments for vasomotor symptoms of menopause; Summarize the risks and benefits of selective estrogen receptor modulators for treatment of symptoms of menopause.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Depression in Pregnancy

Explain the etiology of mood disorders and the effect of pregnancy on these conditions; Diagnose major depressive disorder and related disorders during pregnancy; Counsel a pregnant woman with depression who is concerned about the effects of medication on her child; List the signs of neonatal withdrawal from selective serotonin reuptake inhibitors; Effectively manage postpartum psychosis.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Opiate Use Disorders/Antibiotic Resistance

Utilize a single-question screening test to screen for opiate use; Employ the motivational interviewing approach to encourage patients with substance use disorders to make positive changes in behavior; Adopt the Centers for Disease Control and Prevention guidelines for the use of opioids for noncancer pain; Identify the approved indications for newer antimicrobial drug combinations; Adopt strategies to reduce the inappropriate prescribing of antibiotics.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Cognitive Issues in Affective Disorders

Define hot and cold cognition; Manage recovery from depression in a patient who reports difficulty returning to work; Summarize the expected findings on imaging during performance of a cognitive task for a patient with depression; List antidepressants with direct procognitive effects; Select appropriate candidates for treatment of depression with liraglutide.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Highlights from Scripps' 38th Annual Conference: Clinical Hematology and Oncology 2018

Compare the characteristics and prognosis between human papillomavirus (HPV)-positive and HPV-negative head and neck cancer; Summarize the efficacy and toxicity of chemotherapy and radiation therapy for high-risk and locally advanced head and neck cancer; Identify factors associated with response to immunotherapy in metastatic head and neck cancer; Discuss the relationship between risk scores from multiparameter genomic assays for breast cancer and patient outcomes; Explain how spatial heterogeneity within a tumor and temporal heterogeneity between a primary breast tumor and distant metastases affect response to therapy.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Update on Melanoma and Sarcoma Therapy

Counsel a patient asking about the side effects of immunotherapies for metastatic melanoma; Select appropriate treatments for a patient with metastatic melanoma based on characteristics of the patient and the tumor; Explain how talimogene laherparepvec (T-Vec) is created; Critique a recent study that described a relationship between previous treatment with BRAF inhibitors and the effectiveness of immunotherapies for metastatic melanoma; Assess data of the efficacy of ipilimumab plus nivolumab, compared with nivolumab alone, in the treatment of sarcoma.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Diabetes/Obesity

Manage blood sugar in a hospitalized patient with diabetes; Create an order set for insulins used for inpatient treatment; List common drugs that may promote weight gain; Select appropriate candidates for weight loss medications and bariatric surgery; Summarize the side effects of drugs approved for treatment of obesity.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Parathyroid Hormone

Summarize the pathophysiology of disorders involving excess and deficiency of parathyroid hormone (PTH); Differentiate the anabolic and catabolic effects of PTH; Cite literature documenting therapeutic effects of PTH and its analogues; Optimize the use of analogues of PTH for the treatment of osteoporosis; Select appropriate candidates for treatment of hypoparathyroidism with recombinant human PTH.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Anxiety, PTSD, OCD, and Related Disorders in Primary Care

Explain the pathophysiology of anxiety; Diagnose a patient with an anxiety disorder; Manage anxiety and comorbidities; Choose an appropriate add-on therapy for a patient with a psychiatric disorder who responds only partially to a selective serotonin reuptake inhibitor; Order follow-up tests to detect side effects of second-generation antipsychotics.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Diabetic Macular Edema

Implement appropriate treatment strategies to manage diabetic macular edema; Counsel a diabetic patient about the importance of timely, regular treatment of diabetic eye disease; Recognize the roles of anti-vascular endothelial growth factor (EGF) agents and corticosteroids in the management of diabetic macular edema; Anticipate systemic risks associated with intraocular anti-EGF treatment; Explain the effect of EGF on perfusion in the diabetic retina.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Depression in Pregnancy

Explain the etiology of mood disorders and the effect of pregnancy on these conditions; Diagnose major depressive disorder and related disorders during pregnancy; Counsel a pregnant woman with depression who is concerned about the effects of medication on her child; List the signs of neonatal withdrawal from selective serotonin reuptake inhibitors; Effectively manage postpartum psychosis.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Opiate Use Disorders/Antibiotic Resistance

Utilize a single-question screening test to screen for opiate use; Employ the motivational interviewing approach to encourage patients with substance use disorders to make positive changes in behavior; Adopt the Centers for Disease Control and Prevention guidelines for the use of opioids for noncancer pain; Identify the approved indications for newer antimicrobial drug combinations; Adopt strategies to reduce the inappropriate prescribing of antibiotics.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Update on Melanoma and Sarcoma Therapy

Counsel a patient asking about the side effects of immunotherapies for metastatic melanoma; Select appropriate treatments for a patient with metastatic melanoma based on characteristics of the patient and the tumor; Explain how talimogene laherparepvec (T-Vec) is created; Critique a recent study that described a relationship between previous treatment with BRAF inhibitors and the effectiveness of immunotherapies for metastatic melanoma; Assess data of the efficacy of ipilimumab plus nivolumab, compared with nivolumab alone, in the treatment of sarcoma.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Parathyroid Hormone

Summarize the pathophysiology of disorders involving excess and deficiency of parathyroid hormone (PTH); Differentiate the anabolic and catabolic effects of PTH; Cite literature documenting therapeutic effects of PTH and its analogues; Optimize the use of analogues of PTH for the treatment of osteoporosis; Select appropriate candidates for treatment of hypoparathyroidism with recombinant human PTH.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Menopause

List absolute and relative contraindications to hormone replacement therapy during and after menopause; Explain why transdermal estrogen is preferred over other routes for treatment of vasomotor symptoms of menopause; Manage a patient with vasomotor symptoms who is taking tamoxifen; Counsel a patient regarding effective and ineffective nonpharmacologic treatments for vasomotor symptoms of menopause; Summarize the risks and benefits of selective estrogen receptor modulators for treatment of symptoms of menopause.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Cognitive Issues in Affective Disorders

Define hot and cold cognition; Manage recovery from depression in a patient who reports difficulty returning to work; Summarize the expected findings on imaging during performance of a cognitive task for a patient with depression; List antidepressants with direct procognitive effects; Select appropriate candidates for treatment of depression with liraglutide.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Highlights from Scripps' 38th Annual Conference: Clinical Hematology and Oncology 2018

Compare the characteristics and prognosis between human papillomavirus (HPV)-positive and HPV-negative head and neck cancer; Summarize the efficacy and toxicity of chemotherapy and radiation therapy for high-risk and locally advanced head and neck cancer; Identify factors associated with response to immunotherapy in metastatic head and neck cancer; Discuss the relationship between risk scores from multiparameter genomic assays for breast cancer and patient outcomes; Explain how spatial heterogeneity within a tumor and temporal heterogeneity between a primary breast tumor and distant metastases affect response to therapy.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Diabetes/Obesity

Manage blood sugar in a hospitalized patient with diabetes; Create an order set for insulins used for inpatient treatment; List common drugs that may promote weight gain; Select appropriate candidates for weight loss medications and bariatric surgery; Summarize the side effects of drugs approved for treatment of obesity.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Anxiety, PTSD, OCD, and Related Disorders in Primary Care

Explain the pathophysiology of anxiety; Diagnose a patient with an anxiety disorder; Manage anxiety and comorbidities; Choose an appropriate add-on therapy for a patient with a psychiatric disorder who responds only partially to a selective serotonin reuptake inhibitor; Order follow-up tests to detect side effects of second-generation antipsychotics.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Alternative Medicine, Family Practice and Psychiatry

If you have taken the current Clinical Pharmacology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.